ライフサイエンスコーパス: gingival crevicular fluid

1 esent at up to 70% of serum concentration in gingival crevicular fluid.

2 tching could enhance DOX availability in the gingival crevicular fluid after its release from the col

3 linical trails to reduce MMP activity in the gingival crevicular fluid and gingival tissues, with a r

4 ssive periodontitis have type-1 cytokines in gingival crevicular fluid and high titers of IFN-gamma-d

5 ependent IgG2 reactive with P. gingivalis in gingival crevicular fluid and serum.

6 egulated and is detected at higher levels in gingival crevicular fluid and tissue specimens.

7 antiviral and inflammatory cytokines in the gingival crevicular fluid, and a synergistic effect was

8 peptides are secreted--specifically saliva, gingival crevicular fluid, and airway surface fluid--dif

9 tissues, effect on alveolar bone, effect on gingival crevicular fluid, and effect on salivary flow.

10 study, we examined whether IgG in serum and gingival crevicular fluid, and IgG locally produced by p

11 Bioassay of doxycycline in gingival crevicular fluid associated with presence of AB

12 unstimulated whole-mouth salivary flow rate, gingival crevicular fluid biomarkers).

13 L), and bleeding on probing (BOP) as well as gingival crevicular fluid bone marker assessment (ICTP)

14 nvestigate if levels of IL-1alpha protein in gingival crevicular fluid can be correlated to patient g

15 tudy, we performed a metabolomic analysis of gingival crevicular fluid collected from healthy, gingiv

16 The analysis of gingival crevicular fluid components offers great potent

17 igh levels of gingipain activity detected in gingival crevicular fluid could implicate a role for gin

18 rs could be used for measuring ions from the gingival crevicular fluid directly into the peri-odontal

19 Antibiotics at concentrations detectable in gingival crevicular fluid do not dramatically reduce tot

20 At control sites, a significant decrease in gingival crevicular fluid flow rate was evident at the c

21 evels of galactose-deficient IgG in sera and gingival crevicular fluid from periodontal disease patie

22 combinant segments of FN and used to analyze gingival crevicular fluid from periodontal disease sites

23 their association with plaque index (PI) and gingival crevicular fluid (GCF) after OHR for 1 week.

24 ver, little is known about MMP reductions in gingival crevicular fluid (GCF) after therapy.

25 pth (PD) and local inflammatory mediators in gingival crevicular fluid (GCF) among patients with untr

26 microbial testing, histological examination, gingival crevicular fluid (GCF) analysis for the levels

27 d with that in chronic periodontitis (CP) by gingival crevicular fluid (GCF) analysis of myeloperoxid

28 vels in peri-implant crevicular fluid (PICF)/gingival crevicular fluid (GCF) and a selection of subgi

29 At each visit, gingival crevicular fluid (GCF) and blood were collected

30 whether specific FN fragments are present in gingival crevicular fluid (GCF) and can be used as marke

31 s study were to delineate cyto/chemokines in gingival crevicular fluid (GCF) and evaluate systemic le

32 een the levels of stress-related hormones in gingival crevicular fluid (GCF) and extent/severity of p

33 PAF levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT)

34 LTB4 levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT)

35 The gingival crevicular fluid (GCF) and monocytic secretion

36 onal flap surgery on growth factor levels in gingival crevicular fluid (GCF) and periodontal healing.

37 e aim of the present study is to investigate gingival crevicular fluid (GCF) and plasma acute-phase c

38 im of this study is to investigate levels of gingival crevicular fluid (GCF) and plasma TGM-2 and oxi

39 ects of initial periodontal treatment on the gingival crevicular fluid (GCF) and salivary levels of 8

40 rapy during pregnancy on periodontal health, gingival crevicular fluid (GCF) and serum cytokines, and

41 This study is performed to evaluate gingival crevicular fluid (GCF) and serum levels of solu

42 udy is to evaluate YKL-40 and IL-6 levels in gingival crevicular fluid (GCF) and serum of patients wi

43 ory and anti-inflammatory cytokine levels in gingival crevicular fluid (GCF) and serum of rheumatoid

44 6, and tumor necrosis factor (TNF)-alpha, in gingival crevicular fluid (GCF) and serum samples betwee

45 ), and oxidative stress index (OSI) in their gingival crevicular fluid (GCF) and serum were recorded.

46 Gingival crevicular fluid (GCF) and subgingival plaque w

47 sforming growth factor-beta 1 (TGF-beta1) in gingival crevicular fluid (GCF) and the periodontal stat

48 ociated with apoptosis in serum, saliva, and gingival crevicular fluid (GCF) and their association wi

49 riodontitis-specific molecular signatures in gingival crevicular fluid (GCF) and to confirm clinical

50 PG) levels and RANKL/OPG ratios in serum and gingival crevicular fluid (GCF) are investigated in pati

51 Volumetric alterations in gingival crevicular fluid (GCF) are widely accepted to b

52 in peri-implant crevicular fluid (PICF) and gingival crevicular fluid (GCF) as surrogate measures of

53 of this study is to determine whether either gingival crevicular fluid (GCF) bacterial gingivain/ging

54 ives of this study were to measure levels of gingival crevicular fluid (GCF) biomarkers and subgingiv

55 Gingival crevicular fluid (GCF) biomarkers associated wi

56 e present study are to: 1) determine whether gingival crevicular fluid (GCF) chemerin is a novel pred

57 rformed an unbiased metabolomic profiling of gingival crevicular fluid (GCF) collected from healthy,

58 omitans (Aa), Tannerella forsythia (Tf), and gingival crevicular fluid (GCF) concentration of interle

59 e aim of this study was to compare serum and gingival crevicular fluid (GCF) concentrations of sICAM-

60 amed tissue, suggesting that their levels in gingival crevicular fluid (GCF) could be increased at gi

61 It may be hypothesized that the gingival crevicular fluid (GCF) cytokine profile in pati

62 n-surgical periodontal therapy (NSPT) on the gingival crevicular fluid (GCF) cytokine profile in site

63 Aims of the study are to determine serum and gingival crevicular fluid (GCF) endocan levels in the pa

64 Gingival crevicular fluid (GCF) flow was significantly l

65 luid (PICF) samples from the new implant and gingival crevicular fluid (GCF) from adjacent teeth were

66 the presence of Th1-associated cytokines in gingival crevicular fluid (GCF) from LagP patients and t

67 platelet-derived growth factor (PDGF-BB) in gingival crevicular fluid (GCF) from localized intrabony

68 m human gingival fibroblasts in vitro and in gingival crevicular fluid (GCF) in a randomized controll

69 te and compare the levels of resistin in the gingival crevicular fluid (GCF) in health, chronic perio

70 rleukin (IL)-11 and IL-17 and their ratio in gingival crevicular fluid (GCF) in patients with AgP.

71 he clinical parameters of disease and on the gingival crevicular fluid (GCF) inflammatory mediator in

72 s, levels of eight oral pathogens, levels of gingival crevicular fluid (GCF) interleukin-1beta (IL-1b

73 outh) on clinical periodontal parameters and gingival crevicular fluid (GCF) levels of 15-epi-lipoxin

74 bulin G (IgG) titers to 17 bacteria, and the gingival crevicular fluid (GCF) levels of 16 inflammator

75 The current study determines gingival crevicular fluid (GCF) levels of fibrosis-relat

76 he purpose of this study was to test whether gingival crevicular fluid (GCF) levels of IL-1beta and t

77 ssessing clinical periodontal parameters and gingival crevicular fluid (GCF) levels of interleukin (I

78 Gingival crevicular fluid (GCF) levels of interleukin (I

79 Serum, saliva, and gingival crevicular fluid (GCF) levels of interleukin (I

80 mine whether glycemic control was related to gingival crevicular fluid (GCF) levels of interleukin-1b

81 en the outcome of a chairside test measuring gingival crevicular fluid (GCF) levels of the enzyme asp

82 Gingival crevicular fluid (GCF) levels of the polymorpho

83 Four different gingival crevicular fluid (GCF) markers from 14 patients

84 Different gingival crevicular fluid (GCF) matrix metalloproteinase

85 he aim of this study is to explore different gingival crevicular fluid (GCF) matrix metalloproteinase

86 on clinical and microbiologic parameters and gingival crevicular fluid (GCF) matrix metalloproteinase

87 ncreased levels of immunoglobulin A (IgA) in gingival crevicular fluid (GCF) may be "protective", whi

88 The analysis of biomarkers in gingival crevicular fluid (GCF) may be helpful in foreca

89 e presence of inflammatory products found in gingival crevicular fluid (GCF) may be of value in evalu

90 Biochemical markers harvested from gingival crevicular fluid (GCF) may be useful to identif

91 Estimation of serum and gingival crevicular fluid (GCF) MCP levels could be a re

92 of this study is to investigate salivary and gingival crevicular fluid (GCF) nitric oxide (NO) metabo

93 pare them with their corresponding levels in gingival crevicular fluid (GCF) obtained from the same p

94 ined by enzyme-linked immunosorbent assay in gingival crevicular fluid (GCF) of 24 individuals with p

95 study is to determine visfatin levels in the gingival crevicular fluid (GCF) of healthy individuals a

96 aims to investigate the levels of sTREM-1 in gingival crevicular fluid (GCF) of individuals without p

97 ctoferrin, 2 microbiostatic proteins, in the gingival crevicular fluid (GCF) of normal children.

98 s have previously demonstrated that IgG from gingival crevicular fluid (GCF) of patients with chronic

99 nuclear factor-kappaB ligand (RANKL) in the gingival crevicular fluid (GCF) of patients with periodo

100 hesized that ADAM8 levels are also raised in gingival crevicular fluid (GCF) of patients with periodo

101 ypothesis that TACE would be elevated in the gingival crevicular fluid (GCF) of persons with periodon

102 lagen degradation and bone resorption in the gingival crevicular fluid (GCF) of the same vulnerable s

103 nalysis of alveolar bone, and measurement of gingival crevicular fluid (GCF) prostaglandin E2 (PGE2)

104 ketorolac tromethamine mouthrinse (0.1%) on gingival crevicular fluid (GCF) prostaglandin E2 (PGE2)

105 DL-arginine naphthylamine [BANA] assay), and gingival crevicular fluid (GCF) pyridinoline cross-linke

106 Gingival crevicular fluid (GCF) samples and clinical par

107 on the following: 1) biochemical content in gingival crevicular fluid (GCF) samples from sites of gi

108 Clinical periodontal parameters and gingival crevicular fluid (GCF) samples were collected a

109 fter assessment of periodontal measurements, gingival crevicular fluid (GCF) samples were taken at on

110 cation of multiple inflammatory mediators in gingival crevicular fluid (GCF) samples.

111 erase chain reaction was performed using the gingival crevicular fluid (GCF) samples.

112 ocally delivered antibiotics on the level of gingival crevicular fluid (GCF) stromelysin (SL) and tis

113 The hypothesis to be tested was that gingival crevicular fluid (GCF) TGF-beta1 production was

114 zithromycin are higher and more sustained in gingival crevicular fluid (GCF) than in serum.

115 d tetracyclines reach steady-state levels in gingival crevicular fluid (GCF) that are several-fold hi

116 Secondary purposes were to compare gingival crevicular fluid (GCF) volume and GCF concentra

117 plaque index (PI), gingival index (GI), and gingival crevicular fluid (GCF) volume from days 0 to 21

118 l index (GI), bleeding on probing (BOP), PD, gingival crevicular fluid (GCF) volume, and total amount

119 Clinical evaluation was performed, and gingival crevicular fluid (GCF) was collected for select

120 bleeding on probing (BOP) were measured, and gingival crevicular fluid (GCF) was collected from five

121 Gingival crevicular fluid (GCF) was collected in a cohor

122 The mean concentration of 0.5% CLM in gingival crevicular fluid (GCF) was estimated by reverse

123 The volume of gingival crevicular fluid (GCF) was quantified, and inte

124 Gingival crevicular fluid (GCF) was sampled for the anal

125 Levels of visfatin in serum and gingival crevicular fluid (GCF) were explored in patient

126 Samples of gingival crevicular fluid (GCF) were obtained 1, 3, 7, 1

127 clinical status and the enzymatic profile of gingival crevicular fluid (GCF) when given as adjunct to

128 Beta-glucuronidase (betaG) in gingival crevicular fluid (GCF), a marker of neutrophil

129 Saliva, gingival crevicular fluid (GCF), and blood samples from

130 from necrotic cells, has been identified in gingival crevicular fluid (GCF), and elevated levels are

131 he expression patterns of ghrelin in saliva, gingival crevicular fluid (GCF), and gingival tissue, as

132 ts of subgingival temperature, flow rates of gingival crevicular fluid (GCF), and neutrophil emigrati

133 The aim of this study is to evaluate gingival crevicular fluid (GCF), saliva, and plasma leve

134 This study investigates whether gingival crevicular fluid (GCF), saliva, and plasma leve

135 MMP-9, and TIMP-1 levels were determined in gingival crevicular fluid (GCF), saliva, and serum by im

136 The aim of this study is to evaluate the gingival crevicular fluid (GCF), saliva, and serum conce

137 Gingival crevicular fluid (GCF), saliva, and serum level

138 Pharmacokinetic data were obtained from gingival crevicular fluid (GCF), saliva, and serum of ad

139 -17F, IL-17A/F, and IL-17E (IL-25) levels in gingival crevicular fluid (GCF), saliva, and serum of no

140 Gingival crevicular fluid (GCF), serum, and saliva sampl

141 l blood, as well as gingival tissue (GT) and gingival crevicular fluid (GCF), was obtained from a tot

142 s with data on microbial plaque composition, gingival crevicular fluid (GCF)-interleukin (IL)-1beta l

143 ganic substrates are different in saliva vs. gingival crevicular fluid (GCF).

144 t local anti-PC and anti-oxLDL production in gingival crevicular fluid (GCF).

145 ential amino acid, enters the oral cavity in gingival crevicular fluid (GCF).

146 esent study are to comparatively analyze the gingival crevicular fluid (GCF)/peri-implant sulcus flui

147 were found between DHA and control for both gingival crevicular fluid hsCRP (-5.3 ng/mL, standard er

148 pathogens) and local inflammatory response (gingival crevicular fluid IL-1beta) and derive periodont

149 n and bone loss, which correlated with lower gingival crevicular fluid levels of proinflammatory medi

150 ts in response to a major human salivary and gingival crevicular fluid LPA species, 18:1, and that th

151 n clinical parameters and cytokine levels in gingival crevicular fluid of dogs with experimental peri

152 clinical parameters and cytokine profiles in gingival crevicular fluid of patients with moderate-to-s

153 ipocytokines were evaluated in the serum and gingival crevicular fluid of shallow and deep sites by e

154 y, we detected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythi

155 Gingival crevicular fluid samples from six healthy, six

156 Gingival crevicular fluid samples were analyzed for chan

157 Marginal and subgingival plaque and gingival crevicular fluid samples were collected at base

158 Marginal and subgingival plaque and gingival crevicular fluid samples were collected from 15

159 Gingival crevicular fluid samples were used to monitor d

160 4) relative attachment levels (RAL); and 5) gingival crevicular fluid volume (GCF).

161 In addition, gingival crevicular fluid was analyzed for an inflammati

162 Gingival crevicular fluid was collected before treatment

163 The mean concentration of MF in gingival crevicular fluid was estimated by reverse-phase

164 Plaque and gingival crevicular fluid were collected for trypsin-lik

165 ngivalis-specific immunoglobulin G levels in gingival crevicular fluid were measured in primates immu

166 Samples of gingival crevicular fluid were obtained 1, 3, 7, 14, and